Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells

Philipp Karschnia, Kevin C. Miller, Andrew J. Yee, Kai Rejeski, P. Connor Johnson, Noopur Raje, Matthew J. Frigault, Jorg Dietrich

Blood (2023) 142 (14): 1243–1248.

https://doi.org/10.1182/blood.2023020571

Published: 2023

Journal Articles

Emergence of Chronic Myeloid Leukemia in Patients with Myeloproliferative Neoplasms: A Single-Institution Experience

Kevin C. Miller, Jennifer Lombardi Story, Julia Foster, Jenna A. Moran, Amir T. Fathi, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 12295–12296.

https://doi.org/10.1182/blood-2022-170986

Published: 2022

Journal Articles

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Peter G. Miller, Dandi Qiao, Joselyn Rojas-Quintero, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie E. McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George T. O’Connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Vasan Ramachandran, Bing Yu, Lynette Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert, for the COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium

Blood (2022) 139 (3): 357–368.

https://doi.org/10.1182/blood.2021013531

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Zaid Abdel Rahman, MD, Michael G. Heckman, Kevin C. Miller, BS, Patricia Greipp, DO, Matthew R Spiegel, Sharad Khurana, MDMSc, Hassan B. Alkhateeb, MD, Mrinal M Patnaik, MDMBBS, Lisa Z. Sproat, MD, Liuyan Jiang, Vivek Roy, MD, Mark Litzow, MD, Mohamed A Kharfan-Dabaja, MDMBA, William J Hogan, MB, BCh, James M. Foran, MD

Blood (2019) 134 (Supplement_1): 2588.

https://doi.org/10.1182/blood-2019-122068

Published: 2019

Journal Articles

Salvage Autologous Stem Cell Transplantation in Multiple Myeloma: Investigating the Impact of Pre-Transplant Therapy

Kevin C. Miller, BS, Morie A. Gertz, MD, Francis K. Buadi, MB, CHB, Suzanne R. Hayman, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, David Dingli, MD PhD, Prashant Kapoor, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J. Hogan, MB, BCh, Shaji K. Kumar, MD

Blood (2018) 132 (Supplement 1): 4613.

https://doi.org/10.1182/blood-2018-99-116863

Published: 2018

Journal Articles

A Potential Therapy for Beta-Thalassemia (ST-400) and Sickle Cell Disease (BIVV003)

Michael C. Holmes, PhD, Andreas Reik, PhD, Edward J. Rebar, PhD BS, Jeffrey C. Miller, PhD, Yuanyue Zhou, Lei Zhang, PhD, Patrick Li, Sagar Vaidya

Blood (2017) 130 (Supplement 1): 2066.

https://doi.org/10.1182/blood.V130.Suppl_1.2066.2066

Published: 2017

Journal Articles

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

Kevin C. Miller, BS, Aref Al-Kali, MD, William J. Hogan, MBBCh, Michelle A. Elliott, MD, Kebede H. Begna, MD, Naseema Gangat, MBBS, Mrinal M. Patnaik, MDMBBS, Lisa Sproat, MD MSW, James M. Foran, MD, Mark R. Litzow, MD, Hassan B. Alkhateeb, MD

Blood (2017) 130 (Supplement 1): 5010.

https://doi.org/10.1182/blood.V130.Suppl_1.5010.5010

Published: 2017

Journal Articles

Acute Lymphoblastic Leukemia/Lymphoma in the Elderly: The Mayo Clinic Experience

Blood (2017) 130 (Supplement 1): 1294.

https://doi.org/10.1182/blood.V130.Suppl_1.1294.1294

Published: 2017

Journal Articles

Structural basis for collagen recognition by the immune receptor OSCAR

Long Zhou, Jennifer M. Hinerman, Michal Blaszczyk, Jeanette L. C. Miller, Deborah G. Conrady, Alexander D. Barrow, Dimitri Y. Chirgadze, Dominique Bihan, Richard W. Farndale, Andrew B. Herr

Blood (2016) 127 (5): 529–537.

https://doi.org/10.1182/blood-2015-08-667055

Published: 2016

Includes: Supplemental data

Journal Articles

In vivo genome editing of the albumin locus as a platform for protein replacement therapy

Rajiv Sharma, Xavier M. Anguela, Yannick Doyon, Thomas Wechsler, Russell C. DeKelver, Scott Sproul, David E. Paschon, Jeffrey C. Miller, Robert J. Davidson, David Shivak, Shangzhen Zhou, Julianne Rieders, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar, Katherine A. High

Blood (2015) 126 (15): 1777–1784.

https://doi.org/10.1182/blood-2014-12-615492

Published: 2015

Includes: Supplemental data

Journal Articles

Serum Free Light Chains Identify Patients With Monoclonal Gammopathy At Increased Risk Of Developing Renal Disease

Lawrence R. Johnson, MD, Gerald C. Miller, Ph.D., Spencer R. Stout, MD

Blood (2013) 122 (21): 1876.

https://doi.org/10.1182/blood.V122.21.1876.1876

Published: 2013

Journal Articles

Targeted Gene Modification In Hematopoietic Stem Cells: A Potential Treatment For Thalassemia and Sickle Cell Anemia

Blood (2013) 122 (21): 434.

https://doi.org/10.1182/blood.V122.21.434.434

Published: 2013

Journal Articles

Robust ZFN-mediated genome editing in adult hemophilic mice

Xavier M. Anguela, Rajiv Sharma, Yannick Doyon, Jeffrey C. Miller, Hojun Li, Virginia Haurigot, Michelle E. Rohde, Sunnie Y. Wong, Robert J. Davidson, Shangzhen Zhou, Philip D. Gregory, Michael C. Holmes, Katherine A. High

Blood (2013) 122 (19): 3283–3287.

https://doi.org/10.1182/blood-2013-04-497354

Published: 2013

Includes: Supplemental data

Journal Articles

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

Blood (2013) 122 (8): 1341–1349.

https://doi.org/10.1182/blood-2013-03-478255

Published: 2013

Includes: Supplemental data

Journal Articles

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

Hiroki Torikai, Andreas Reik, Pei-Qi Liu, Yuanyue Zhou, Ling Zhang, Sourindra Maiti, Helen Huls, Jeffrey C. Miller, Partow Kebriaei, Brian Rabinovitch, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Luigi Naldini, Edward J. Rebar, Philip D. Gregory, Michael C. Holmes, Laurence J. N. Cooper

Blood (2012) 119 (24): 5697–5705.

https://doi.org/10.1182/blood-2012-01-405365

Published: 2012

Includes: Supplemental data

Journal Articles

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

Lubka T. Roumenina, Marie Frimat, Elizabeth C. Miller, Francois Provot, Marie-Agnes Dragon-Durey, Pauline Bordereau, Sylvain Bigot, Christophe Hue, Simon C. Satchell, Peter W. Mathieson, Christiane Mousson, Christian Noel, Catherine Sautes-Fridman, Lise Halbwachs-Mecarelli, John P. Atkinson, Arnaud Lionet, Veronique Fremeaux-Bacchi

Blood (2012) 119 (18): 4182–4191.

https://doi.org/10.1182/blood-2011-10-383281

Published: 2012

Journal Articles

Evaluation of Single Agent Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma (NDMM).

Rachid Baz, Mohamad Hussein, MD, Daniel J. Lebovic, MD, Elizabeth Finley-Oliver, RN, Mehul P Patel, MB, BS, Hong Liu, Kena C Miller, NP, Margaret Wood, Kelvin P. Lee, MD, Asher Chanan-Khan, MD

Blood (2009) 114 (22): 3868.

https://doi.org/10.1182/blood.V114.22.3868.3868

Published: 2009

Journal Articles

Geographical Variation Shows Differences in Disease Characteristics Among Patients with Multiple Myeloma.

Sikander Ailawadhi, MD, Michael Keng, MD, Ann Mohrbacher, MD, Eddie Thara, MD, Dongyun Yang, PhD, Taimur Sher, MD, Mehul P Patel, MB, BS, Kena C Miller, NP, Susan Groshen, PhD, Asher A. Chanan-Khan, MD

Blood (2009) 114 (22): 4895.

https://doi.org/10.1182/blood.V114.22.4895.4895

Published: 2009

Journal Articles

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study.

Taimur Sher, MD, Kena C Miller, Sikander Ailawadhi, MD, Debbie Manfredi, Margaret Wood, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Hong Liu, MD, Myron S Czuczman, MD, Francisco Hernandez, MD, Frederick Hong, MD, Raman Sood, MD, Saif Soniwalla, MD, William Lawrence, MD, Peter A. Kouides, MD, Kelvin P. Lee, MD, Asher Chanan-Khan, MD

Blood (2009) 114 (22): 618.

https://doi.org/10.1182/blood.V114.22.618.618

Published: 2009

Journal Articles

Phase I Study of IMGN901, Used as Monotherapy, in Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Safety and Efficacy Analysis.

Asher Chanan-Khan, MD, Jeffrey Wolf, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Debbie Manfredi, Kelvin P. Lee, MD, Kena C Miller, NP, Robin Guild, Sybil Zildjian, MPH, Albert Qin, MD, Ph.D., James O'Leary, MD, Robert Vescio, MD

Blood (2009) 114 (22): 2883.

https://doi.org/10.1182/blood.V114.22.2883.2883

Published: 2009

NARROW

Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells

Emergence of Chronic Myeloid Leukemia in Patients with Myeloproliferative Neoplasms: A Single-Institution Experience

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Salvage Autologous Stem Cell Transplantation in Multiple Myeloma: Investigating the Impact of Pre-Transplant Therapy

A Potential Therapy for Beta-Thalassemia (ST-400) and Sickle Cell Disease (BIVV003)

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

Acute Lymphoblastic Leukemia/Lymphoma in the Elderly: The Mayo Clinic Experience

Structural basis for collagen recognition by the immune receptor OSCAR

In vivo genome editing of the albumin locus as a platform for protein replacement therapy

Serum Free Light Chains Identify Patients With Monoclonal Gammopathy At Increased Risk Of Developing Renal Disease

Targeted Gene Modification In Hematopoietic Stem Cells: A Potential Treatment For Thalassemia and Sickle Cell Anemia

Robust ZFN-mediated genome editing in adult hemophilic mice

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

Evaluation of Single Agent Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma (NDMM).

Geographical Variation Shows Differences in Disease Characteristics Among Patients with Multiple Myeloma.

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study.

Phase I Study of IMGN901, Used as Monotherapy, in Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Safety and Efficacy Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only